Alan Tan, MD | Faculty | RUSH University

Dr. Alan Tan

Claim this profile

Rush University Medical Center

Studies Thyroid Cancer
Studies Kidney Cancer
15 reported clinical trials
26 drugs studied

Area of expertise

1Thyroid Cancer
Alan Tan has run 9 trials for Thyroid Cancer. Some of their research focus areas include:
Stage IV
Stage III
TFEb positive
2Kidney Cancer
Alan Tan has run 6 trials for Kidney Cancer. Some of their research focus areas include:
Stage IV
TFEb positive
TFE3 positive

Affiliated Hospitals

Image of trial facility.
Rush University Medical Center
Image of trial facility.
Vanderbilt University/Ingram Cancer Center

Clinical Trials Alan Tan is currently running

Image of trial facility.

Radium-223 + Cabozantinib

for Kidney Cancer with Bone Metastasis

This phase II trial studies whether adding radium-223 dichloride to the usual treatment, cabozantinib, improves outcomes in patients with renal cell cancer that has spread to the bone. Radioactive drugs such as radium-223 dichloride may directly target radiation to cancer cells and minimize harm to normal cells. Cabozantinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving radium-223 dichloride and cabozantinib may help lessen the pain and symptoms from renal cell cancer that has spread to the bone, compared to cabozantinib alone.
Recruiting1 award Phase 216 criteria
Image of trial facility.

Apalutamide + Hormone and Radiation Therapies

for Prostate Cancer

This phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgens, or male sex hormones, can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may help stop or reduce the growth of prostate cancer cell growth by blocking the attachment of androgen to its receptors on cancer cells, a mechanism similar to stopping the entrance of a key into its lock. Adding apalutamide to the usual hormone therapy and radiation therapy after surgery may stabilize prostate cancer and prevent it from spreading and extend time without disease spreading compared to the usual approach.
Recruiting2 awards Phase 3

More about Alan Tan

Clinical Trial Related4 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 6 Active Clinical Trials
Treatments Alan Tan has experience with
  • Nivolumab
  • Ipilimumab
  • Pembrolizumab
  • Avelumab
  • Cabozantinib
  • Axitinib

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alan Tan specialize in?
Alan Tan focuses on Thyroid Cancer and Kidney Cancer. In particular, much of their work with Thyroid Cancer has involved Stage IV patients, or patients who are Stage III.
Is Alan Tan currently recruiting for clinical trials?
Yes, Alan Tan is currently recruiting for 6 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Alan Tan has studied deeply?
Yes, Alan Tan has studied treatments such as Nivolumab, Ipilimumab, Pembrolizumab.
What is the best way to schedule an appointment with Alan Tan?
Apply for one of the trials that Alan Tan is conducting.
What is the office address of Alan Tan?
The office of Alan Tan is located at: Rush University Medical Center, Chicago, Illinois 60612 United States. This is the address for their practice at the Rush University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security